Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RXST · against 220 other Healthcare companies of similar size
Ranked #133 of 221 · scores higher than 40% of peers
Bars: peers in each 10-point band of the profitability score27 peers with a profitability score of 20–29, including RXST · Click a bar to see the companies
Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | RXST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 184 reported | -17.4% | -2.5% | 37% | 33% | |
| Operating marginHigher is better · 201 reported | -43.2% | 0.4% | 30% | 33% | |
| Return on assetsHigher is better · 224 reported | -2.3% | -2.0% | 48% | 33% | |
| Return on equityHigher is better · 207 reported | -17.3% | -4.8% | 39% | Context only | |
| Gross marginHigher is better · 237 reported | 77.5% | 41.3% | 84% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 261M USD | 98 | 97 | |
| 2 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 356M AUD (≈$235M) | 97 | 81 | |
| 4 | 592M ILS (≈$160M) | 96 | 84 | |
| 5 | 301M USD | 95 | 67 | |
| 129 | 318M USD | 27 | 26 | |
| 129 | 172M USD | 27 | 34 | |
| 131 | 2.1B CNY (≈$301M) | 26 | 21 | |
| 131 | 200M USD | 26 | 30 | |
| 133 | 191M USD | 25 | 38 | |
| 134 | 2.4B CNY (≈$331M) | 24 | 51 | |
| 134 | 2.1B CNY (≈$291M) | 24 | 9 | |
| 136 | 2.7B CNY (≈$381M) | 23 | 28 | |
| 136 | 7.1B TWD (≈$221M) | 23 | 25 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score